Background: Oxytocin and various prostaglandin preparations are commonly used for pharmacological induction of labor at term. Some prostaglandin preparations appear to be associated with more fetal meconium passage and maternal gastrointestinal side effects than is oxytocin. These adverse effects may be caused by stimulation of bowel smooth muscle in the mother and in the fetus.

Aim: To determine whether the in vitro ileal contractile activities of dinoprostone, misoprostol and oxytocin are in keeping with the variation in rates of meconium staining observed during labor induction with these substances.

Methods: The contractile activity of the drugs was tested on isolated rat uterus and ileum mounted in Tyrode's solution.

Results: Uterine contractions were stimulated by all three drugs, whereas ileal contractions were only stimulated by dinoprostone and misoprostol. Oxytocin had no contractile activity on the ileum. Dinoprostone and misoprostol stimulated significantly (p < 0.05) larger uterine contractions than ileal contractions.

Conclusion: These results provide a pharmacological basis for the increased rate of maternal gastrointestinal complaints and meconium passage with labor induction using dinoprostone and misoprostol compared to oxytocin. Based on the above findings, we postulate that the difference in the rates of meconium passage following misoprostol and dinoprostone administration is caused by pharmacokinetic rather than pharmacodynamic differences between the two drugs.

Download full-text PDF

Source
http://dx.doi.org/10.1515/JPM.2002.063DOI Listing

Publication Analysis

Top Keywords

dinoprostone misoprostol
20
labor induction
12
meconium passage
12
effects oxytocin
8
prostaglandin preparations
8
maternal gastrointestinal
8
misoprostol oxytocin
8
rates meconium
8
contractile activity
8
uterine contractions
8

Similar Publications

Background: Labor induction is a common obstetric intervention, increasingly performed worldwide, often using prostaglandins like misoprostol and dinoprostone.

Objective: This study aims to compare the effectiveness and safety of intravaginal misoprostol versus dinoprostone for inducing labor, examining their impact on various maternal and neonatal outcomes.

Methods: A systematic review and meta-analysis were conducted using four databases-PubMed, Google Scholar, EBSCO, and the Cochrane Library-from January 2000 to April 2023.

View Article and Find Full Text PDF

This study investigates the various methods of pain management during the insertion of intrauterine devices (IUDs) in nulliparous women. Currently, the only recommended method of pain management is 800 mg of ibuprofen taken one hour before insertion of the IUD. However, women continue to experience pain during the procedure.

View Article and Find Full Text PDF

Background: Induction of labor is the process of artificially stimulating the uterus to start labor before the spontaneous onset of labor. It has several medical indications. Commonly used agents are vaginal misoprostol, vaginal prostaglandin E2 (dinoprostone), and oral misoprostol.

View Article and Find Full Text PDF
Article Synopsis
  • Bone cells produce FGF23, a hormone that helps regulate phosphate and vitamin D levels, with elevated FGF23 linked to chronic kidney disease and cardiovascular issues.
  • The study examined how Prostaglandin E (PGE), particularly through its receptor EP2, influences FGF23 production in bone cells, and found that PGE significantly enhances FGF23 levels.
  • Using different mouse models, the research showed that PGE signaling through EP2 and the transcription factor Nurr1 is critical for FGF23 production, suggesting potential clinical implications for conditions involving inflammation and kidney health.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!